Start breast cancer screening at 40, but screen every two years, USPSTF says. Will America listen? May 12, 2023Vol.49 No.19By Matthew Bin Han Ong
Conversation with The Cancer Letter USPSTF’s Wanda Nicholson: Screening saves lives, but screening alone won’t fix disparities in cancer deaths May 12, 2023Vol.49 No.19By Matthew Bin Han Ong
Guest Editorial USPSTF breast cancer screening guidelines are clear, concise; now let’s address gaps in quality May 12, 2023Vol.49 No.19By Otis W. Brawley
Clinical Roundup Breast cancer tumors disrupt the immune system remotely favoring their own growth, animal study suggests May 05, 2023Vol.49 No.18
Clinical Roundup Roswell Park immunologists identify targetable strategy for reducing solid-tumor cancer metastasis April 28, 2023Vol.49 No.17
Clinical Roundup IU cancer researchers identify target for breast cancer therapy April 21, 2023Vol.49 No.16
Clinical Roundup Benefit of chemotherapy for early-stage breast cancer varies by tumor anatomy, Roswell Park study shows April 21, 2023Vol.49 No.16
Trials & Tribulations San Antonio Breast Cancer Symposium 2022 tackled big obstacles, recommended solutions for breast cancer progress April 14, 2023Vol.49 No.15By Angela DeMichele, Rajarshi Sengupta and Carlos L. Arteaga
